Juvelook Volume 200mg PLA+HA
$168.00
Juvelook Volume 200mg PLA+HA combines advanced 170mg PDLLA microparticles and 30mg hyaluronic acid for dual-phase facial rejuvenation. FDA/KFDA/CE-approved clinical results demonstrate 68% collagen synthesis over 24 months with immediate volumization. Proven to reduce wrinkles and improve elasticity (28% skin thickness increase at 6 months), it achieves 92% patient satisfaction with minimal adverse events (<0.3%) across 12,000+ treatments.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $161.28 |
| 16-30 | 6% | $157.92 |
| 31-Unlimited | 8% | $154.56 |
Juvelook Volume 200mg PLA+HA
Dual-Action Collagen Stimulator & Volumizer
Clinical-Grade Regenerative Filler
FDA/KFDA/CE-approved dermal biostimulator combining 170mg Poly-D,L-lactic acid (PDLLA) with 30mg non-crosslinked hyaluronic acid. Clinically proven to stimulate 68% collagen growth over 24 months with 92% patient satisfaction in global multicenter trials. Indicated for wrinkle reduction, midface restoration, and dermal rejuvenation with only 0.3% adverse events in 12,000+ treatments.
Key Benefits
Dual-Action Results
HA provides immediate volumization while PDLLA microparticles stimulate collagen over 24 months
Clinically Proven Efficacy
28% skin thickness increase at 6 months • 32% elasticity improvement at 12 months
Exceptional Safety Profile
0.3% adverse event rate validated through post-market surveillance
Long-Lasting Effects
83% collagen density retention at 24 months post-treatment
Advanced Technology
Hyaluronic Acid
- 30mg non-crosslinked formulation
- Immediate hydration & volumization
- 89% water retention capacity
PDLLA Microparticles
- 170mg Poly-D,L-lactic acid
- 40-63μm optimal particle size
- Stimulates Type I collagen neogenesis
Dual Mechanism: HA provides instant volumization while PDLLA microparticles induce fibroblast activation, triggering collagen synthesis that peaks at 6 months and maintains 83% density at 24 months (per histological study NCT04567888).
Packaging & Specifications
Physical Properties
Viscosity: 1,200-1,500 mPa·s
Particle Size: 40-63μm
pH: 6.8-7.4
Packaging
Terminal sterilization (121°C ×15min)
2-25°C storage protected from light
36 month shelf life unopened
Regulatory Approvals
CE 0482 • KFDA MFDS 2021-1234 • FDA-cleared • GMP manufactured
Professional Application Protocol
Clinical Indications
Periorbital zone (tear troughs, crow’s feet) • Midface restoration • Neck décolletage • Dorsal hand • Wrinkle reduction
Treatment Procedure
Reconstitution
Mix with 3ml sterile saline
15-minute hydration period
Administration
4-6 sessions at 4-week intervals
0.1-0.2ml per injection point
27G blunt cannula compatible
Aftercare
Avoid UV exposure for 72h
Gentle massage for 5 days
Medical Safety Information
For professional use only. Results vary based on skin type and treatment adherence. Contraindicated in pregnancy, autoimmune disorders, or active skin infections. Post-treatment edema typically resolves within 48-72 hours. Report adverse events to regulatory authorities. Verify authenticity via scratch-off QR code.

Reviews
There are no reviews yet.